Yanming Biology
Signal active
Organization
Contact Information
Overview
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.
About
Industries
Biotechnology, Pharmaceutical, Therapeutics
Founded
2020
Employees
0
Headquarters locations
Asia
Social
N/A
Profile Resume
Yanming Biology headquartered in Asia, operates in the Biotechnology, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $2.3B in funding across 24 round(s). Their latest funding round, Series A - Yanming Biology, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
8
Lead Investors
0
Total Funding Amount
$96.8M
Details
2
Yanming Biology has raised a total of $96.8M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Early Stage Venture | 96.8M | ||
| 2024 | Early Stage Venture |
Investors
Yanming Biology is funded by 23 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Frees Fund | - | FUNDING ROUND - Frees Fund | undefined |
| Life Garden Venture capital | - | FUNDING ROUND - Life Garden Venture capital | undefined |
| Yanming Biology | - | FUNDING ROUND - Yanming Biology | undefined |
| Qinglan Fund | - | FUNDING ROUND - Qinglan Fund | undefined |
Recent Activity
There is no recent news or activity for this profile.